Cellular Biomedicine Group, Inc.
(NASDAQ : CBMG)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -2.51%429.580.0%$5879.67m
BNTXBioNTech SE -4.53%355.790.0%$1225.84m
NVAXNovavax, Inc. -1.77%233.0779.4%$922.71m
SNSSSunesis Pharmaceuticals, Inc. 0.12%8.530.7%$596.28m
AMGNAmgen, Inc. -0.11%217.131.4%$527.37m
REGNRegeneron Pharmaceuticals, Inc. -1.19%645.432.7%$516.57m
GILDGilead Sciences, Inc. -0.70%70.831.0%$418.67m
ILMNIllumina, Inc. -0.50%447.683.5%$378.22m
TECHBio-Techne Corp. 1.05%535.004.5%$331.75m
BIIBBiogen, Inc. -0.63%297.801.7%$290.94m
VRTXVertex Pharmaceuticals, Inc. -0.29%186.551.9%$229.88m
ISEEIVERIC bio, Inc. -1.53%16.110.0%$186.23m
BGNEBeiGene Ltd. 4.77%403.621.3%$167.00m
LIFEaTyr Pharma, Inc. -5.75%9.673.2%$131.31m
KDMNKadmon Holdings, Inc. -0.57%8.770.9%$127.36m

Company Profile

Cellular Biomedicine Group, Inc. is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in Rockville, MD.